LAURA MORRIS: Open Payments
NPI 1629092853 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 29 payments from 12 companies in 2025. Trend: 2023 $459 · 2024 $555 · 2025 $735
Food & beverage: $735
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $151 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $98 |
| Amgen Inc. | 5 | $80 |
| CVRx, Inc. | 1 | $62 |
| Merck Sharp & Dohme LLC | 3 | $58 |
| Inspire Medical Systems, Inc. | 2 | $58 |
| Chiesi USA, Inc. | 2 | $54 |
| Boston Scientific Corporation | 2 | $48 |
| Novo Nordisk Inc | 2 | $47 |
| Edwards Lifesciences Corporation | 1 | $31 |
Products named: LEQVIO, Kerendia, REPATHA, Barostim Neo System, INSPIRE, JUXTAPID, WATCHMAN FLX, Wegovy.
Industry payments across GA — which companies pay providers there.
